Empowered Funds’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.37M | Buy |
9,822
+4,632
| +89% | +$2.06M | 0.05% | 480 |
|
2025
Q1 | $2.52M | Sell |
5,190
-2,629
| -34% | -$1.27M | 0.04% | 630 |
|
2024
Q4 | $3.15M | Sell |
7,819
-4,786
| -38% | -$1.93M | 0.05% | 537 |
|
2024
Q3 | $5.86M | Sell |
12,605
-17,482
| -58% | -$8.13M | 0.09% | 313 |
|
2024
Q2 | $14.1M | Buy |
30,087
+23,348
| +346% | +$10.9M | 0.24% | 72 |
|
2024
Q1 | $2.82M | Sell |
6,739
-5,287
| -44% | -$2.21M | 0.05% | 493 |
|
2023
Q4 | $4.89M | Buy |
12,026
+9,836
| +449% | +$4M | 0.12% | 237 |
|
2023
Q3 | $762K | Buy |
2,190
+386
| +21% | +$134K | 0.02% | 767 |
|
2023
Q2 | $635K | Buy |
1,804
+652
| +57% | +$229K | 0.02% | 748 |
|
2023
Q1 | $363K | Sell |
1,152
-8,517
| -88% | -$2.68M | 0.02% | 433 |
|
2022
Q4 | $2.79M | Buy |
9,669
+2,334
| +32% | +$674K | 0.18% | 81 |
|
2022
Q3 | $2.12M | Buy |
+7,335
| New | +$2.12M | 0.21% | 106 |
|